Ocean Medical Center, part of Meridian CardioVascular Network, has received the Mission: Lifeline® Bronze Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks.
Every year, more than 250,000 people experience an ST elevation myocardial infarction (STEMI) the most deadly type of heart attack caused by a blockage of blood flow to the heart that requires timely treatment. To prevent death, it's critical to restore blood flow as quickly as possible, either by mechanically opening the blocked vessel or by providing clot-busting medication.
The American Heart Association's Mission: Lifeline program's goal is to reduce system barriers to prompt treatment for heart attacks, beginning with the 9-1-1 call and continuing through hospital treatment.
"Ocean Medical Center is dedicated to improving the quality of care for our patients who suffer a heart attack, and the American Heart Association's Mission: Lifeline program is helping us accomplish that goal through nationally respected clinical guidelines," said Richard M. Neibart, M.D., medical director of Meridian CardioVascular Network. "We are pleased to be recognized for our dedication and achievements in cardiac care, and I am very proud of our team."
"We commend Ocean Medical Center for this achievement award, which reflects a significant institutional commitment to the highest quality of care for their heart attack patients," said James G. Jollis, MD, Chair of the Mission: Lifeline Advisory Working Group. "Achieving this award means the hospital has met specific reporting and achievement measures for the treatment of their patients who suffer heart attacks and we applaud them for their commitment to quality and timely care."
Ocean Medical Center earned the award by meeting specific criteria and standards of performance for the quick and appropriate treatment of STEMI patients by providing emergency procedures to re-establish blood flow to blocked arteries when needed. Eligible hospitals must adhere to these measures at a set level for at least one consecutive 90 day interval.
Researchers uncover key mechanisms of CRISPR gene editing